BNP PARIBAS ASSET MANAGEMENT Holding S.A. reduced its stake in ResMed Inc. ($RMD) by 17.5% in the third quarter, selling 41,123 shares. Despite this, other hedge funds increased their positions, and institutional investors now own 54.98% of the stock. Analysts maintain a “Moderate Buy” rating for ResMed, with a consensus price target of $299.27.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
ResMed Inc. $RMD Shares Sold by BNP PARIBAS ASSET MANAGEMENT Holding S.A.
BNP PARIBAS ASSET MANAGEMENT Holding S.A. reduced its stake in ResMed Inc. ($RMD) by 17.5% in the third quarter, selling 41,123 shares. Despite this, other hedge funds increased their positions, and institutional investors now own 54.98% of the stock. Analysts maintain a “Moderate Buy” rating for ResMed, with a consensus price target of $299.27.